In hormone receptor-positive (HR+) breast cancer, tumours positive for rearrangement-mediated expressed gene fusions resulted in overall lower survival for patients relative to those with tumours negative for gene fusions [146,147,148]. This evidence concerns the gene NR4A1 and neoplasm.